Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

Multiple myeloma (MM), a clonal plasma cell disorder, disrupts the bones’ hematopoiesis and microenvironment homeostasis and ability to mediate an immune response against malignant clones. Despite prominent survival improvement with newer treatment modalities since the 2000s, MM is still considered...

Full description

Bibliographic Details
Main Authors: Max Von Suskil, Kazi Nasrin Sultana, Weam Othman Elbezanti, Omar S. Al-Odat, Robert Chitren, Amit K. Tiwari, Kishore B. Challagundla, Sandeep Kumar Srivastava, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
multiple myeloma
microenvironment
Bruton’s Tyrosine Kinase (BTK) inhibitors
resistance
drug development
Online Access:https://www.mdpi.com/1422-0067/22/11/5707

Internet

https://www.mdpi.com/1422-0067/22/11/5707

Similar Items